![Stephen J. Moloney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen J. Moloney
Keine laufenden Positionen mehr
Profil
Stephen J.
Moloney worked as a European Medical Director at Aspreva Pharmaceuticals Corp.
from 2005 to 2008.
He then worked as a Senior Medical Director at Shire Human Genetic Therapies, Inc. from 2008 to 2014.
In 2014, he became the Executive Medical Director at Aegerion Pharmaceuticals, Inc. until 2015.
From 2015 to 2017, he worked as the Vice President-Medical Affairs at PTC Therapeutics, Inc. He also worked as the Vice President-Global Medical Affairs at Strongbridge Biopharma Plc.
Dr. Moloney earned a doctorate degree from the University of Bristol.
Ehemalige bekannte Positionen von Stephen J. Moloney
| Unternehmen | Position | Ende |
|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2017 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2015 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2014 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2008 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | - |
Ausbildung von Stephen J. Moloney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
